Skip to main content

Year: 2022

Ilkka Oyj – Acquisition of own shares on 23 December 2022

ILKKA OYJ, STOCK EXCHANGE RELEASE, 23 December 2022 at 19:00 EET Ilkka Oyj – Acquisition of own shares on 23 December 2022 At Nasdaq Helsinki Ltd:Date 23 December 2022Exchange transaction BuyShare trading code ILKKA2Amount, shares  1,500Average price/share, EUR 3.6367Total cost, EUR 5,455.05  The company holds a total of 17,908 of its own shares (ILKKA2) including the shares acquired on 23 December 2022. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg        Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 www.ilkka.comAttachmentIlkka buyback 23.12.2022

Continue reading

Rovio Entertainment Corporation: Repurchase of own shares on 23 December 2022

Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 23.12.2022 at 18.45 EET   Rovio Entertainment Corporation – Repurchase of own shares on 23.12.2022   Rovio Entertainment Corporation  In the Nasdaq Helsinki  Date 23.12.2022Exchange transaction BUYShare trading code ROVIOAmount, shares 16053Average price/share, EUR 6,064074Total cost, EUR 97346,58      Rovio now holds a total of 6 847 734 shares including the shares repurchased on 23.12.2022   On behalf of Rovio Entertainment Corporation     OP Corporate Bank PLC  Further information:Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution:Nasdaq Helsinki LtdKey mediawww.rovio.com About Rovio:Rovio Entertainment Corporation is a global mobile-first games company that creates,...

Continue reading

FDA approves Roche’s Lunsumio, a first-in-class bispecific antibody, to treat people with relapsed or refractory follicular lymphoma

With Lunsumio, people with heavily pre-treated follicular lymphoma may experience remission with a chemotherapy-free, fixed-duration treatment that can be accessed in an outpatient setting Results from the pivotal phase II GO29781 study demonstrated that 80% of patients who received at least two prior therapies achieved durable response rates, with 60% experiencing complete remission Lunsumio is now the first CD20xCD3 T-cell engaging bispecific antibody approved by the FDA to treat the most common slow-growing form of non-Hodgkin lymphoma, follicular lymphomaBasel, 23 December 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Lunsumio® (mosunetuzumab-axgb) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two...

Continue reading

Replay Link Available for TMRC Webinar Discussion of Geophysical Results of New Mexico’s Blackhawk Silver Mining Project

SIERRA BLANCA, TX, Dec. 23, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Texas Mineral Resources Corp. (OTCQB: TMRC), targeting the rare earths, industrial and technology metals through its 20% ownership interest in the Round Top Mountain project in Texas and ongoing exploration initiatives, is pleased to announce that on December 22, 2022, Dan Gorski, CEO, and Anthony Marchese, Chairman, held a webinar discussing the geophysical results and economic potential of the New Mexico Blackhawk silver mining project. A link to the replay may be found here: https://bit.ly/3veLhXa using password: *pxfWo2d About Texas Mineral Resources Corp.Texas Mineral Resources Corp.’s primary focus is to develop and commercialize, along with its joint venture operating partner USA Rare Earth LLC, the Round Top heavy-rare earth, technology metals,...

Continue reading

Subsea 7 S.A. notice to investors

Luxembourg – 23 December 2022 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY, the “Company”) today announced that, following the implementation of the Norwegian Central Securities Depository Act, implementing the EU Central Securities Depositories Regulation (CSDR) and the decision of the board of directors under the authorisation given to it by the extraordinary general meeting of the Company on 12 April 2022, the compulsory dematerialisation of all the existing shares in the Company is now effective. All issued shares in the Company have been converted into dematerialised shares and the Company’s articles of incorporation have been amended to remove the references to provisions that were applicable until such conversion.   In the context of the dematerialisation of its shares, the Company has appointed Verdipapirsentralen ASA (operating...

Continue reading

Current Water Technologies Inc. 2022 AGSM Results

GUELPH, Ontario, Dec. 23, 2022 (GLOBE NEWSWIRE) — Current Water Technologies Inc. (TSX-V: WATR) (“CWTI” or “the Company” or “the Corporation”), is pleased to announce the results of its Annual General and Special Meeting (“AGSM”) that was held at 10:00 am on December 23, 2022. The shareholders approved all resolutions presented in the Information Circular sent to the Company’s shareholders and filed on SEDAR on December 1, 2022. At the AGSM the shareholders:Received the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2021 with the comparative statements for the previous fiscal period ended December 31, 2020, together with the report of the auditors thereon. Approved the appointment of the following four (4) persons as Directors...

Continue reading

SAGALIAM ACQUISITION CORP. CONFIRMS FUNDING AND EXTENSION OF DEADLINE TO COMPLETE INITIAL BUSINESS COMBINATION

New York, NY, Dec. 23, 2022 (GLOBE NEWSWIRE) — Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“we”, “us”, “our”, or the “Company”) announced today that it was exercising its option to extend the time available to consummate its business combination to January 23, 2023 and our sponsor, Sagaliam Sponsor LLC, has deposited an aggregate of $57,380.22 into Company’s trust account for its public stockholders. This deposit enables the Company to extend the date by which the Company has to complete its initial business combination from December 23, 2022 to January 23, 2023 (the “Extension”). The Extension is the first of ten one-month extensions permitted under the Company’s governing documents. About Sagaliam Acquisition Corp. We are a blank check company incorporated under the laws of the State of Delaware on March 31,...

Continue reading

Transport for Greater Manchester orders another 50 electric buses from NFI subsidiary Alexander Dennis for next stage of Bee Network roll-out

NFI – Alexander Dennis electric bus for TfGM’s Bee Network NFI – Alexander Dennis electric bus for TfGM’s Bee NetworkLARBERT, Scotland, Dec. 23, 2022 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, subsidiary Alexander Dennis Limited (“Alexander Dennis”) today announced receipt of an order for an additional 50 zero-emission double-deck buses from Transport for Greater Manchester, doubling the total on order for the franchised Bee Network bus system to 100. These additional 50 British-built electric buses will enter service in parts of Bury, Rochdale and Oldham when the second tranche of franchising launches there in April 2024, delivering a cleaner, more environmentally...

Continue reading

Kalera Shareholders Approve Reverse Stock Split

Kalera ordinary shares expected to begin trading on a split-adjusted basis on December 23, 2022 Orlando, Florida, Dec. 23, 2022 (GLOBE NEWSWIRE) — Kalera Public Limited Company (“Kalera” or the “Company”) (Nasdaq: KAL), a vertical farming company headquartered in Orlando, Florida, today announced that shareholders approved a reverse stock split of its outstanding ordinary shares (the “Ordinary Shares”) at a ratio of 100-for-1. The reverse stock split will become effective today, December 23, 2022, and Ordinary Shares will begin trading on a split-adjusted basis when the Nasdaq opens today. The Ordinary Shares will continue to trade on the Nasdaq under the existing trading symbol “KAL”. The reverse stock split was approved by Kalera’s shareholders at the extraordinary general meeting held on December 22, 2022 (the “EGM”). The reverse...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.